Heart disease continues to be one of the leading causes of mortality worldwide and in Saudi Arabia. Yet, the future of cardiovascular care is being rewritten — not just through clinical expertise, but through biotechnology, bioengineering, and innovative solutions that transform how we prevent, diagnose, and treat heart conditions.
HeartFusion 2025 is a premier international conference jointly hosted by Johns Hopkins Aramco Healthcare (JHAH) in partnership with King Fahd University of Petroleum and Minerals (KFUPM). This unique event will bring together cardiologists, researchers, bioengineers, healthcare innovators, and policymakers to explore the latest advancements addressing one of Saudi Arabia’s most urgent health challenges – cardiovascular disease. Over three dynamic days, from November 6–8, 2025, participants will engage in a rich program that bridges lab discoveries and clinical practice, offering unparalleled opportunities to learn, collaborate, and innovate.
Why HeartFusion 2025 is Unique
- Innovation at the Core: Focused on biotech and bioengineering solutions, the conference highlights emerging technologies such as bioengineered cardiac devices, AI-driven decision support, patientcentered remote monitoring systems, and predictive analytics tools.
- Global Expertise: Hear from internationally recognized keynote speakers, thought leaders, and clinical experts who are advancing cardiovascular care on a global scale.
- Interdisciplinary Collaboration: Connect with a diverse audience of clinicians, researchers, engineers, and industry leaders — fostering partnerships that accelerate the translation of research into real-world impact.
- Hands-On Learning: Participate in workshops, live demonstrations, and interactive sessions designed to equip attendees with actionable skills in cutting-edge cardiac technologies.
- Research and Recognition: Present your own work, engage in peer-reviewed abstract sessions, and gain visibility in a forum dedicated to shaping the next era of cardiology.
Conference Focus
HeartFusion 2025 centers on five key innovation drivers that are shaping modern cardiovascular care:
- Smart Biotech Integration in Cardiology – Advanced bioengineered devices, regenerative therapies, and biomaterials that redefine cardiac treatment.
- Data-Driven Decision Support Tools – AI-powered algorithms, predictive analytics, and real-time biomarker integration for precise, patient-specific care.
- Preventive Cardiac Health & Risk Stratification Early detection and proactive interventions powered by biotechnology and molecular diagnostics.
- Patient-Centered Remote Monitoring Systems – Wearables, implantable sensors, and telehealth platforms enabling continuous, personalized care.
- Workforce Training for Future-Ready Cardiology Teams – Preparing clinicians and allied professionals to adopt new technologies and lead in precision cardiology.
Who Should Attend
HeartFusion 2025 is designed for:
- Clinical Professionals: Cardiologists, cardiac surgeons, nurses, allied health professionals, and medical students
- Researchers & Academics: Researchers and academic professionals in cardiovascular science and bioengineering
- Innovators & Entrepreneurs: Healthcare innovators and biotech entrepreneurs
- Decision-Makers: Policymakers, hospital administrators, and industry leaders shaping cardiovascular care strategies
Experience the Future of Cardiovascular Care
Heart Fusion 2025 is not just a conference; it is a movement toward a healthier heart for all. By attending, you will:
- Witness groundbreaking research and emerging technologies
- Gain practical skills from workshops and live demos
- Collaborate with peers and thought leaders globally
- Contribute to shaping the future of cardiovascular care
Join us at HeartFusion 2025: Shaping the Future of Cardiovascular Care through Biotechnology Innovation
